Spyre Therapeutics Inc

NEW
FRA:3920 (USA)  
€ 75.5 -3.5 (-4.43%) Aug 31
At Loss
P/B:
8.24
Market Cap:
€ 6.80B ($ 7.88B)
Enterprise V:
€ 5.93B ($ 6.88B)
Volume:
23.00
Avg Vol (2M):
122.00
Trade In:

My Checklist

Inactive
Item Name
Rating
Action

Fair Value Votes

Date Voted
Fair Value
Price on Date Voted
% Change Since Voted
% Change Relative to SP500
10/Page
Total 0

My Votes

My Vote : €